Prosensa Holding Reaches New 12-Month Low at $5.63 (RNA)
Prosensa Holding (NYSE:RNA)’s share price reached a new 52-week low during trading on Tuesday, AnalystRatings.Net reports. The stock traded as low as $5.63 and last traded at $5.70, with a volume of 659,113 shares traded. The stock had previously closed at $6.19.
A number of analysts have recently weighed in on RNA shares. Analysts at JPMorgan Chase & Co. downgraded shares of Prosensa Holding from an “overweight” rating to a “neutral” rating in a research note to investors on Tuesday, September 24th. They now have a $6.50 price target on the stock, down previously from $35.00. Separately, analysts at Wedbush downgraded shares of Prosensa Holding from an “outperform” rating to a “neutral” rating in a research note to investors on Monday, September 23rd. They now have a $7.00 price target on the stock, down previously from $50.00. Finally, analysts at Citigroup Inc. downgraded shares of Prosensa Holding from a “buy” rating to a “neutral” rating in a research note to investors on Monday, September 23rd.
Prosensa Holding has a 1-year low of $5.65 and a 1-year high of $34.55. The stock’s 50-day moving average is $17.5 and its 200-day moving average is $22.2. The company’s market cap is $159.2 million.
Prosensa Holding N.V., formerly Prosensa Holding B.V., is a biotechnology company engaged in the discovery and development of ribonucleic acid-modulating (NYSE:RNA)-modulating, therapeutics for the treatment of genetic disorders.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.